Cannabidiol
- Generic Name
- Cannabidiol
- Brand Names
- Epidiolex, Sativex, Epidyolex
- Drug Type
- Small Molecule
- Chemical Formula
- C21H30O2
- CAS Number
- 13956-29-1
- Unique Ingredient Identifier
- 19GBJ60SN5
- Background
Cannabidiol, or CBD, is one of at least 85 active cannabinoids identified within the Cannabis plant. It is a major phytocannabinoid, accounting for up to 40% of the Cannabis plant's extract, that binds to a wide variety of physiological targets of the endocannabinoid system within the body. Although the exact medical implications are currently being investig...
- Indication
When used in combination with delta-9-tetrahydrocannabinol as the product Sativex, cannabidiol was given a standard marketing authorization (ie. a Notice of Compliance (NOC)) by Health Canada for the following indications:
...
- Associated Conditions
- Multiple Sclerosis, Seizures, Severe Pain, Moderate Pain
- Associated Therapies
- -
Research on Cognitive Effect of Cannabidiol on Dravet Syndrome and Lennox-Gastaut SyndromeGastaut Syndrome
- First Posted Date
- 2020-11-02
- Last Posted Date
- 2020-11-02
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 107
- Registration Number
- NCT04611438
- Locations
- 🇰🇷
Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
Topical CBD in Joint Arthritis
- First Posted Date
- 2020-11-02
- Last Posted Date
- 2020-11-02
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 40
- Registration Number
- NCT04611347
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Does Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Study
- Conditions
- Interventions
- First Posted Date
- 2020-10-28
- Last Posted Date
- 2023-08-18
- Lead Sponsor
- King's College London
- Target Recruit Count
- 36
- Registration Number
- NCT04605393
- Locations
- 🇬🇧
South London and Maudsley NHS Foundation Trust, London, United Kingdom
The Effect of Cannabidiol on Lean Body Mass in Patients Receiving Chemotherapy
- Conditions
- Interventions
- First Posted Date
- 2020-10-14
- Last Posted Date
- 2023-07-24
- Lead Sponsor
- University of Copenhagen
- Target Recruit Count
- 32
- Registration Number
- NCT04585841
- Locations
- 🇩🇰
Zealand University Hospital, Roskilde, Denmark
A Study to Evaluate the Outcomes of Cannabinoid (CBD) Roll-on Topical Stick in Primary Total Knee Arthroplasty
- Conditions
- Interventions
- First Posted Date
- 2020-10-14
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Rothman Institute Orthopaedics
- Target Recruit Count
- 92
- Registration Number
- NCT04585230
- Locations
- 🇺🇸
Rothman Orthopaedic Institute, Philadelphia, Pennsylvania, United States
Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBI
- Conditions
- Interventions
- First Posted Date
- 2020-09-16
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 120
- Registration Number
- NCT04550377
- Locations
- 🇺🇸
New York University School of Medicine, New York, New York, United States
Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism
- Conditions
- Interventions
- First Posted Date
- 2020-08-18
- Last Posted Date
- 2023-03-30
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 42
- Registration Number
- NCT04517799
- Locations
- 🇺🇸
University of California San Diego, La Jolla, California, United States
Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19
- Conditions
- Interventions
- First Posted Date
- 2020-08-07
- Last Posted Date
- 2021-09-28
- Lead Sponsor
- University of Sao Paulo
- Target Recruit Count
- 120
- Registration Number
- NCT04504877
- Locations
- 🇧🇷
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP, Ribeirão Preto, SP, Brazil
RCT of CBD for Anxiety in Advanced Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2020-07-22
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 50
- Registration Number
- NCT04482244
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms
- First Posted Date
- 2020-07-13
- Last Posted Date
- 2021-09-28
- Lead Sponsor
- University of Sao Paulo
- Target Recruit Count
- 100
- Registration Number
- NCT04467918
- Locations
- 🇧🇷
Unidade de Pronto Atendimento/UPA - 13 de Maio/Dr. Luis Atílio Losi Viana (UPA Covid), Ribeirão Preto, São Paulo, Brazil
🇧🇷Serviço de Assistência Médica e Social do Pessoal do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirão Preto, SP, Brazil
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.